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Detergent resistant membranes (DRMs) are the site of assembly for a variety of viruses. Here, we make use of Sendai virus mutant proteins that
are not packaged into virus particles to determine the involvement of this assembly for the virus particle production. We found that, in the context
of an infection, (1) all the Sendai virus proteins associated in part with DRMs, (2) mutant HN and M proteins not packaged into virus particles
were similarly part of this association, (3) after M protein suppression resulting in a significant reduction of virus production, the floatation profile
of the other viral proteins was not altered and finally (4) cellular cholesterol depletion did not decrease the virus particle production, although it
somehow reduced their virus infectivity. These results led us to conclude that the assembly complex found in DRM fractions does not constitute a
direct precursor of virus particle budding.
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Cellular lipid bilayers are composed of a variety of phospho-
and sphingolipids. Also, these membranes are not homoge-
neous, but rather constituted of microdomains of different size
and lipid composition (Edidin, 1997; Simons and Ikonen, 1997).
In the past decade, membrane domains enriched in cholesterol
and glycosphingolipids received a particular attention, in part,
because they are resistant to detergent solubilization at 4 -C, a
property that facilitates their isolation. These detergent resistant
membranes (DRMs) can cluster to form microdomains, called
‘‘rafts’’. Rafts have been localized at the plasma membrane, in
the Golgi apparatus as well as in the endocytic pathway (van
Meer and Sprong, 2004). They have been associated with
intracellular sorting and signal transduction events, cell adhe-
sion, cell polarity, lipid and protein excretion and host–pathogen
interactions (Golub and Pico, 2005; Ikonen, 2001; Simons and
Ikonen, 1997; Simons and Toorme, 2000; Lafont and van der
Goot, 2005; Manes et al., 2003).
Rafts have also been implicated in virus entry, intracellular
trafficking, assembly and budding, this for a variety of viruses0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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(Pelkmans, 2005; Nayak and Barman, 2002; Chazal and
Gerlier, 2003). For the enveloped negative stranded RNA
viruses, the involvement of rafts in virus entry and budding has
been reported for Influenza virus (Orthomyxovrius, Scheiffele
et al., 1997, 1999; Keller and Simons, 1998; Ali et al., 2000),
Ebola and Marburg viruses (Filovirus, Panchal et al., 2003;
Bavari et al., 2002), Respiratory syncytial, Newcastle disease,
measles and Sendai viruses (Paramyxovirus, Brown et al.,
2002; Dolganiuc et al., 2003; Manie et al., 2000; Vincent et al.,
2000; Ali and Nayak, 2000; Sanderson et al., 1995); for a
recent review on Paramyxovirus budding see Takimoto and
Portner (2004).
For measles virus, a member of the Paramyxoviridae family,
it was shown that the localization of the viral components into
rafts resulted from a cooperative assembly process. The F1
glycoprotein, inherently capable of raft association, was
responsible for dragging the other viral glycoprotein, H, into
the rafts. Similarly, the assembly of the internal viral proteins N
and M into rafts was dependent on the presence of the viral
genome (Manie et al., 2000; Vincent et al., 2000). An
equivalent study has not been performed for Sendai virus.
However, cellular membranes were purified from infected cells
and treated with detergents to investigate the degree of6) 296 – 303
www.e
Fig. 1. Floatation profile of the SeV proteins. After 20 h of infection, SeV
infected LLC-MK2 cells were disrupted in 1% Triton X-100 lysis buffer at 4
-C. The cellular extract was analyzed by floatation in Optiprep gradients as
described in Materials and methods. The protein contents of the fractions
collected from the top of the gradient were separated by PAGE electrophoresis
and characterized by Western blotting, using antibodies specific to the SeV
viral proteins and to caveolin. DRM: fractions containing the light detergent
resistant membranes; Int: intermediate fractions; Sol: fractions containing
solubilized proteins; P: SeV phospho-protein; HN: SeV hemagglutinin-
neuraminidase protein; Fo: SeV uncleaved fusion protein; N: SeV nucleocap-
sid protein; M: SeV matrix protein; Cav: cellular caveolin-1, as marker for
DRMs.
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membranes (Ali and Nayak, 2000; Sanderson et al., 1995).
While M acquired resistance to both Triton X-100 and
octylglucoside extraction, HN and F were resistant only to
Triton X-100 solubilization. When individually expressed from
vaccinia virus recombinants, each viral protein (F, HN or M)
was independently capable of acquiring Triton X-100 insolu-
bility (Sanderson et al., 1995). However, this association with
DRMs was disrupted at Triton X-100 concentrations (0.03–
0.05%) that do not correspond to the solubilization conditions
generally accepted as characteristic of rafts.
The association of viral constituents with rafts has naturally
led to the conclusion that the raft membranes were likely
involved in virus particles budding as well (Manie et al., 2000).
This conclusion may not follow since often, and this is the case
for Sendai virus, a minor fraction of the viral components
assembles into virus particles (Tuffereau and Roux, 1988),
making its tracking difficult. We decided to test the pertinence
of the assembly complex for virus particle production by using
mutant virus proteins, HN and M, known not to be packaged
into virus particles. The rationale of this approach rests on the
prediction that the assembly complex pertinent for virus
particle production should not contain the mutant proteins.
We observed that, in Sendai virus infected cells, association
with DRMs did not necessarily correlate with incorporation
into virus particles. Moreover, in conditions where the M
protein was suppressed, resulting in a significant decrease in
virus particle production, the protein profile of the DRM
fractions was not altered. Finally, cholesterol depletion did not
lead to a decrease of virus particle release. These results led to
the conclusion that the assembly complex found in DRM
fractions does not constitute a direct precursor of virus particle
budding. Another possible route of assembly is discussed.
Results
Association of the Sendai virus proteins with detergent
resistant membranes
Sendai virus infected LLC-MK2 cells were solubilized with
1% Triton X-100 at 4 -C and the cellular extracts were loaded
in OptiPrep gradients (see Materials and methods) to assess the
degree of association of the viral proteins with the detergent
resistant membranes (DRMs). In such gradients, DRMs are
found at the top of the gradient (Fig. 1, DRM, fractions 2–3),
identified, in our case, by the presence of caveolin-1 (Cav), a
constituent of the caveolae, known to harbor light lipid
membranes enriched in cholesterol and sphingolipids (Kurz-
chalia and Parton, 1999; Parton and Richards, 2003; Simons
and Ikonen, 1997). The proteins float in the DRM fractions by
their full association with the low density membranes. In
contrast, the proteins found at the bottom of the gradient
(fractions 7–8, Sol), are fully dissociated from lipid mem-
branes and sediment according to their intrinsic density. The
fractions of intermediate density (fractions 4–6, Int) contain
proteins partially associated with lipid complexes or associated
with membranes of higher density.All the Sendai virus proteins were partly found in the light
DRM fractions (Fig. 1, DRM). Their sedimentation profile,
however, was not homogenous. The P and N proteins, part of
the nucleocapsid complex, appeared evenly distributed
throughout the gradients, with, however, a preponderance for
the intermediate (Int) and DRM fractions (particularly, fraction
3). The two glycoproteins, HN and F, exhibited a biphasic
distribution with an under representation in the intermediate
fractions. In contrast, the M protein appeared enriched in these
intermediate fractions. Identical results were obtained when
floatation gradients were prepared with sucrose solutions in
place of OptiPrep (not shown, see Materials and methods). It is
noteworthy that the M protein, accepted to be the central
organizer of the virus particle formation, was poorly repre-
sented in the DRM fractions.
Are DRM fractions relevant for assembly leading to virus
particle production?
Virus assembly fractions identified as relevant for virus
particle production should be the site of discrimination
between proteins that will become incorporated into virus
particles and proteins that are excluded. We made use of
previously produced mutant HN and M proteins to verify this
assertion. A mutant HN protein, HNct35SIcp, has been
generated which carries a five amino acid substitution in its
cytoplasmic tail (SYWST Y AFYKD; Fouillot-Coriou and
Roux, 2000; see Materials and methods). Upon infection of
LLC-MK2 cells with a recombinant SeV (rSeV-HNct35SIcp)
expressing HNct35SIcp, the mutant HN protein could accu-
mulate at the cell plasma membrane, but was not incorporated
into virus particles in a detectable manner. Interestingly, virus
particle production was normal (Fouillot-Coriou and Roux,
Fig. 3. Floatation profile of SeV wild-type and mutant M proteins. LLC-MK2
cells were infected with a SeV mixed virus stock expressing a HA tagged
version of either the wild-type (1) or the mutant (2) M protein. Cellular extracts
were prepared as in Fig. 1 and the virus particles present in the supernatants
were isolated as described in Materials and methods. (A) 1/13th of the cellular
extracts (CE) or the totality (1/1) of the virus particles (VP) from the SeV/HA-
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with, to the left, the extracts (CE) of cells infected with wild-
type (lane 1) or rSeV-HNct35SIcp (lane 2) viruses and, to the
right, the protein contents of the virus particles (VP). Note that
13-folds less cellular extracts (1/13) than virus particles (1/1)
were analyzed, showing that less that 10% of the viral proteins
were found in virus particles. Next, the DRM membrane
association profile of HNct35SIcp obtained from these infected
cells was compared with that of the HN wild type (Figs. 2B
and C). No difference in the DRM composition was observed
between the two proteins. The floatation profile of the other
viral proteins was also similar for the wild-type and the mutant
virus infected cell extracts (not shown).
A similar analysis of an M protein mutant, HA-M30, was
then performed. HA-M30 carries two mutations T112M and
V113E which prevent incorporation of the protein into virus
particles (Mottet et al., 1999; see Materials and methods). In
this case, the mutant M, tagged with an HA epitope (HA-M),
was expressed from a minigenome supported by a helper virus
(mixed virus stock) expressing a wild-type M. In this context,
HA-M30 was shown (1) not to interact with the wild-type M by
coimmunoprecipitation, (2) to mainly accumulate around the
cell nucleus and (3) to exhibit a partial negative dominant
phenotype on virus particle budding. These features could not
be attributed to the HA tag, since a wild-type HA-M (HA-Mwt)
expressed under the same conditions behaved normally (MottetFig. 2. Floatation profile of SeV wild-type and mutant HN proteins. LLC-MK2
cells were infected with wild-type SeV (1) or with the rSeV-HNct35SIcp mutant
(2). At 20 h post-infection, the cells and their supernatant were collected.
Cellular extracts were prepared as in Fig. 1 and the virus particles present in the
supernatants were isolated as described in Materials and methods. (A) 1/13th of
the cellular extracts (CE) or the totality (1/1) of the virus particles (VP) from the
wild-type (1) or HNct35SIcp mutant (2) was analyzed by Western blotting using
anti SeV HN, N or M specific antibodies, plus anti-caveolin. The remaining
fraction of respectively the wild-type (B) and the HNct35SIcp (C) cellular
extracts were analyzed by floatation gradients as in Fig. 1. HN: HN from wild-
type SeV infected cells; HNmut: HNct35SIcp; DRM, Int, Sol: as in Fig. 1.
M (1) or SeV/HA-M30 mutant (2) was analyzed by Western blotting using anti-
M or anti-HA antibodies. The remaining fraction of respectively SeV/HA-M
(B) or SeV/HA-M30 mutant (C) cellular extracts were analyzed by floatation
gradients as in Fig. 1. HA-M: HA tagged M wild type; HA-M30: HA M30
mutant M; DRM, Int, Sol: as in Fig. 1.et al., 1999). Fig. 3A (CE, part a-M) shows the relative level of
the HA-Ms and Ms expressed in LLC-MK2 cells infected with
the mixed virus stocks, coexpressing HA-Mwt (lane 1) or HA-
M30 (lane 2) along with the normal M. Part [a-HA] scores the
tagged M proteins only. Fig. 3A (VP) shows the same analysis
performed on the virus particles produced and demonstrates the
total absence of HA-M30 (VP part lane 2) scored with the a-
HA in regard to the positive uptake of HA-M wild type (lane
1). Despite the total absence of HA-M30 in virus particles, its
floatation profile in the DRM fractions is unchanged compared
to HA-Mwt (compare Figs. 3B and C, fractions 2–3). However,
an increase of HA-M30 in the soluble portion of the gradient
was reproducibly observed (Fig. 3C, fractions 7–8), which
may relate to the different subcellular localization of the two
proteins (Mottet et al., 1999). As for the sedimentation profile
of the other viral proteins, it did not differ in the two situations
(not shown).
Finally, the floatation profile of the viral proteins was tested
in the absence of detectable M protein, with the idea that the
assembly complex would be severely compromised under
these conditions. To achieve this goal, a recombinant SeV
harboring a siRNA target sequence in its M gene 5V UTR was
grown in cells constitutively expressing the cognate siRNAs
(see Materials and methods). Under these conditions, the
suppression of M, although not complete, became more and
more prominent with time in regard to the amounts of the
A.-S. Gosselin-Grenet et al. / Virology 344 (2006) 296–303 299other viral proteins which steadily increased (Fig. 4A, CE,
compare 18 and 40 h pi). After 40 h of infection, the
suppression was sufficient to provoke a significant reduction
of virus particle production compared to that of the control
infection (Fig. 4A, VP compare lanes 1 and 2). At this later
time, the floatation profiles of the HN, F and N proteins were
compared. The absence of detectable M resulting in the
significant reduction in virus particle production was not
paralleled by a change in the floatation profile of the other
viral proteins (compare Figs. 4B and C).
In summary, the viral composition of the DRM fractions
could not be perturbed either when the viral proteins were
mutated not to be packaged into virus particles, or when the M
protein was suppressed so that virus particle production could
be significantly reduced.
Effect of cholesterol depletion on virus particle production
DRM insolubility properties depend mainly on their high
cholesterol composition. Membrane embedded cholesterol can
be removed by treatment with methyl-h-cyclodextrin (MhCD,
Harder and Simons, 1997). Fig. 5A shows that a 90 min
treatment of cells with 20 mM MhCD causes a depletion ofFig. 5. Effect of cholesterol depletion on the floatation profile of SeV proteins.
(A) Mock infected LLC-MK2 cells were treated with the indicated concentra-
tion of methyl-h-cyclodextrin (MhCD) as described in Materials and methods.
Total cholesterol amount remaining was then estimated by thin layer
chromatography (TLC) as described in Materials and methods and plotted
relative to the amount measured in untreated cells (0 mM MhCD). Cellular
extracts from infected cells mock treated (B) or treated with 20 mM MhCD (C)
in the same conditions as panel A were analyzed by floatation gradients as in
Fig. 1. DRM, Int, Sol: as in Fig. 1.
Fig. 4. Association of the SeV proteins with the DRMs in the absence of the M
protein. A549 cells constitutively expressing siRNAs (A549-siRNAs) directed
against a GFP mRNA sequence (2) or A549 control cells (1) were infected with
rSeV-M(gfpt). Forty hours post-infection, cellular extracts (CE) were prepared
as in Fig. 1 and the virus particles (VP) present in the supernatants were isolated
as described in Materials and methods. (A) 1/13th of the cellular extracts (CE)
or the totality (1/1) of the virus particles (VP) from A549 control cells (1) or
A549-siRNAs (2) were analyzed by Western blotting using anti SeV HN, Fo, N
or M specific antibodies, plus anti-caveolin. The remaining fraction of
respectively the A549 control (B) or A549-siRNAs (C) cellular extracts were
analyzed by floatation gradients as in Fig. 1. DRM, Int, Sol: as in Fig. 1.about 60% of their total cholesterol content. Upon cholesterol
depletion, DRMs undergo some alteration as evidenced by the
caveolin floatation profile which shows a displacement from
the top fractions to the more intermediate positions (Fig. 5C,
Cav). As for the viral proteins, if the HN and Fo protein
profiles exhibited a significant shift towards the soluble
fractions (Figs. 5B and C, HN, Fo), little effect of cholesterol
depletion was seen on the distribution of the N and M proteins
(Figs. 5B and C).
The effect of cholesterol depletion on the virus particle
production was then measured. We rationalized that virus
particle production could be affected by the disruption of the
DRMs if these latters represent the site at which assembly
complex relevant for budding takes place. Infected cells were
then treated with MhCD and the virus particles produced under
these conditions were collected. Fig. 6A shows (duplicate
samples) that MhCD treatment had little effect on the HN and
N content in the cellular extracts (CE). In contrast, a ¨4-fold
decrease in the M protein amount was observed. Interestingly,
the protein profile of the virus particles produced shows a
corresponding increase in the M protein composition following
MhCD treatment (VP). A slight increase in HN was also
observed. Finally, caveolin, not usually found in virus particles
(see also Fig. 2B), was now detected (see Discussion). The
Fig. 6. Effect of cholesterol depletion on virus particle production. SeV infected
LLC-MK2 cells were treated or not (T) with 20 mM MhCD for 90 min at
20 h post-infection. At the end of the MhCD treatment, cellular extracts were
prepared and virus particles produced in the supernatants during the treatment
were isolated as described inMaterials and methods. (A)Western blot analysis of
a fraction the cellular extracts (CE) and virus particles produced, as in Fig. 2A.
Duplicate samples are shown. (B) In separate experiments, the cell supernatants
were treated with trypsin, serially diluted and used in an infectivity titration assay
as described in Materials and methods. The results of two independent
experiments are shown, each being the mean of duplicate samples.
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formation assay (Fig. 6B), and a loss (20–40%) was
reproducibly noticed. Despite these alterations, possibly due
to side effects of the treatment, it remains that DRM disruption
by MhCD treatment resulted in no way in a decrease of
physical virus particle production.
Discussion
Enveloped virus constituents have been shown to assemble
on DRMs, usually described as rafts after their coalescence into
microdomains, and its has been assumed that this assembly is
relevant for virus particle production (Pelkmans and Helenius,
2003; Manes et al., 2003). However, an intrinsic complication
of this logic comes from the minor fraction of the intracellular
virus constituents which, eventually, end up in virus particles.
We therefore designed experiments to assess the relevance of
DRM driven assembly for virus particle production, using
mutant virus proteins excluded from virus particles. The
rationale of this approach rests on the conclusion that their
exclusion should parallel their absence in the assembly
complex, if this latter is relevant for virus particle formation.
The results were clear cut. The representation in the DRM
fractions of the HN and M mutants excluded from virus
particles did not change from that of their wild-type counter-
part. Moreover, the M protein suppression did not provoke an
alteration of the DRM composition, although, under these
conditions, assembly leading to budding was significantly
perturbed, as seen by the significant decrease in virus particleproduction. Taken together, these observations strongly suggest
that the DRM fractions do not constitute sites of viral
component assembly directly related to virus particle produc-
tion. This conclusion was reinforced by the fact that DRM
disruption following cholesterol depletion had no detrimental
effect on the amount of virus particle production. The better
uptake of M (and HN) observed under these conditions is
interesting because it may refer to an alteration of the
regulation of assembly, but remains unexplained at present.
There are different ways to interpret these data. On the one
hand, they may reflect the poor resolution of the DRM
fractions obtained from floatation gradients. These fractions
are certainly heterogeneous, reflecting the heterogeneity and
the constant remodeling of the populations of cholesterol
enriched membranes. On the other hand, the DRM association
may represent an assembly step in the pathway to budding at
which discrimination between the proper virus particle
constituents has not yet segregated away from the contaminants
(be it improper viral or cellular proteins). In that respect, it is
noteworthy that HNct35SIcp is efficiently expressed at the cell
surface (Fouillot-Coriou and Roux, 2000). Yet, its packaging
into virus particles does not take place, despite the fact that its
association with DRM is similar to that of wild-type HN. This
suggests that the cell plasma membrane is not the site at which
HN is incorporated in the assembly complex relevant for
budding. This situation is reminiscent of the observation made
in the study of retrovirus pseudotyping (Sandrin et al., 2004).
The feline endogenous retrovirus RD114 glycoprotein was
found not to pseudotype efficiently with SIV cores, whereas it
does so readily with MLV core. The explanation for this
discrepancy relies on the necessity of the glycoprotein to find
its core on intracellular membranes, after reinternalization from
the cellular plasma membrane. It is then possible that the SeV
HN has to be reinternalized to attach to the nucleocapsid/M
assembly complex. The effect that its SYWST motif, found
essential for incorporation into virus particles, has on its
trafficking has yet to be solved. Similarly, HA-M30 was found
not to migrate to the cell periphery. Yet, its ability to partially
reduce the virus particle production was recognized (Mottet et
al., 1996). In the end, both sets of data point to a site of
assembly relevant for budding located on membranes other
than those identified as cholesterol enriched membranes in the
present study, and possibly not localized at the plasma
membrane.
It is noteworthy that this discrepancy between DRM
association and uptake in virus particle has been reported
before for a Paramyxovirus. Following infection of cells with a
chimeric measles virus (MGV) in which H and F were replaced
by the vesicular stomatitis virus (VSV) G glycoprotein, it was
found that the VSV G protein, in contrast to the measles virus
proteins, did not associate with DRMs. Yet, MGV particles
(containing G) production was found efficient (Vincent et al.,
2000). So, for measles virus, as well as for Sendai viruses, it
appears that the lipid rafts may not represent sites where
partitioning between proteins incorporated or not into virus
particles takes place. Discrimination at the site of rafts has yet
been described for HIV produced by infected T-cell lines
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proteins (Gag and Env, raft associated) are incorporated into
virus particles, but also the GPI anchored cellular proteins Thy-
1 and CD59, as well as the ganglioside GM1, similarly known
to partition into lipid rafts. In contrast, the CD45 protein is
poorly incorporated despite its high cell surface expression, and
this exclusion correlates with an exclusion from the lipid rafts.
In the end, the direct involvement of rafts for virus particle
production may vary from one virus family to another, an
assertion that should not be a surprise considering the extreme
variability with which the viruses have evolved in their
adaptation to their host.
Materials and methods
Cells
LLC-MK2 and A549 cells were grown at 37 -C in Dulbecco
modified Eagle’s medium (DMEM) supplemented with 5%
fetal calf serum (FCS) under 5% CO2 atmosphere. The
preparation of the A549-LV-siGFP cells will be described in
details elsewhere (Mottet Genevie`ve, Laurent Roux and cow-
orkers, Department of Microbiology and Molecular Medicine,
University of Geneva Medical School, in preparation). In brief,
A549 cells were transduced with a lentiviral vector expressing
siRNAs targeted to a defined sequence (gfpt) of the green
fluorescent protein (GFP) gene and the nerve growth factor
receptor (NGFR) as described in Wiznerowicz and Trono
(2003). The transduced cells were selected on the basis of
efficient NGFR surface expression. Efficient expression and
suppression capacity of the siRNAs were probed by GFP
suppression upon infection of the cells with a recombinant SeV
expressing GFP (rSeV-GFP, see below).
Viruses and virus infection
Infections with Sendai virus (SeV), with its various
recombinants (rSeV) or with the mixed Sendai virus stocks
were performed at 33 -C. Virus stocks were adequately diluted
(multiplicity of infection of 3) in MEM without FCS and laid
over the cells for 1 h. At the end of the infection period, the
infectious mix was removed and replaced with fresh MEM
supplemented with 2% FCS. SeV Harris strain was prepared
and characterized as before (Roux and Holland, 1979). rSeV-
HNct35SIcp mutant was generated previously (Fouillot-Coriou
and Roux, 2000). This virus expresses a mutant HN glycopro-
tein carrying an amino acid sequence substitution in its
cytoplasmic domain (change of 10SYWST14 into 10AFYKD14).
This HN protein also harbors an influenza virus hemagglutinin
(HA) epitope tag at its C-terminus (aa 576MAYPYDVP-
DYASLG-GPGA593, Fouillot-Coriou and Roux, 2000). A rSeV
expressing a wild-type HN glycoprotein tagged with the same
HA epitope (rSeV-HA-HNwt) was also generated for compar-
ison (Fouillot-Coriou and Roux, 2000). rSeV-Mgfpt is a
recombinant SeV harboring in its M gene 5V untranslated region
a sequence derived from the GFP gene (5V-AAGAACGGCAU-
CAAGGUGAACUUAGC-3V). rSeV-GFP is a recombinant SeVharboring a supplementary transcription unit in between the M
and the F genes in which the GFP gene was inserted. Detailed
description of the preparation of these two rSeV will be
published elsewhere (Mottet Genevie`ve, Laurent Roux and
coworkers, Department of Microbiology and Molecular Med-
icine, University of Geneva Medical School, in preparation).
Mixed virus stocks containing mini-genomes expressing HA-
tagged versions of the wild-type (HA-Mwt) or mutated M (HA-
M30) protein have been described before (Mottet et al., 1996).
HA-M30 carries Thr112 Y Met and Val113 Y Glu substitutions
resulting in its exclusion from virus particles and in its ability to
interfere with virus particle production (Mottet et al., 1999).
Reagents
Antibodies used in this study include anti-caveolin-1 (N20;
Santa Cruz), anti-SeV P (a rabbit serum raised against SDS-
denatured P protein, a-PSDS), anti-SeV HN (a rabbit serum
raised against SDS-denatured HN protein, a-HNSDS), anti-SeV
Fo (a rabbit serum raised against Fo cytopalsmic tail peptide,
a-Fo), anti-SeV N (a rabbit serum raised against SDS-
denatured N protein, a-NSDS), anti-SeV M (a rabbit serum
raised against SDS-denatured M protein, a-MSDS (Mottet et al.,
1986; Tuffereau and Roux, 1988) and MAb 383 obtained from
Claes O¨rvell (Laboratory of Clinical Virology, Huddinge
Hospital, Huddinge, Sweden), anti-Influenza virus HA epitope
MAb (16b12, Berkeley Antibody Co.). Peroxidase-coupled
secondary antibodies were from BioRad. Methyl-h-cyclodex-
trin was from Sigma.
Methyl-b-cyclodextrin treatment and cholesterol measurement
Methyl-h-cyclodextrin (MhCD) treatment (0, 10, 20 mM)
was performed in serum-free medium during a 90 min period at
37 -C. This treatment led to at least 60% extraction of total
cellular cholesterol quantitatively measured by one-dimension-
al thin layer chromatography (TLC) after CuAc/H3PO4 staining
as described by Abrami et al. (2003).
Detergent resistant membrane preparation and floatation
gradients
Infected cells (107) were lyzed in 300 Al of ice-cold TNE
buffer (25 mM Tris–HCl, pH 7.5; 150 mM NaCl; 5 mM
EDTA) containing 1% Triton X-100 (lysis buffer) plus a
cocktail of protease inhibitors (Complete; Roche). The lysis
buffer volume to cell number ratio was adjusted empirically
according to the sedimentation profile of caveolin-1 and was
kept constant throughout the experiments. Detergent resistant
membranes (DRMs) were separated using OptiPrep (Nyco-
denz). Cellular extracts (200 Al) treated for 30 min at 4 -C with
the lysis buffer were mixed with 400 Al of 60% OptiPrep. This
40% OptiPrep mixture was overlaid with 30% (1200 Al) and
0% (500 Al) OptiPrep layers, and centrifuged for 2 h at 55,000
rpm (4 -C) using a TLS55 Beckman rotor (Lafont et al., 2002).
Alternatively, sucrose gradients were used. In this case, cellular
extracts were made 40% in sucrose (800 Al), overlaid with 35%
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40,000 rpm (16 h, 4 -C) using a SW60 rotor. Fractions were
collected from the top, the protein content of each fraction was
precipitated with 8% TCA in the presence of 375 Ag sodium
deoxylcholate, dissolved in 25 Al of SDS sample buffer and
analyzed by SDS-polyacrylamide gel electrophoresis (PAGE).
SDS-PAGE analyses and Western blotting
Protein samples were analyzed by SDS-PAGE. After
electrophoresis, the proteins were transferred using a semi-
dry system onto polyvinylidene difluoride membranes (Milli-
pore). Blots were then incubated with specific antibodies,
followed by the appropriate horseradish peroxidase (HRP)-
coupled secondary antibodies. Protein detection was performed
by using the enhanced chemiluminescence system (Amersham
Biosciences).
Virus particle characterization
To estimate virus production and to characterize the virus
particle composition, the virus particles in the clarified cell
supernatants were collected by centrifugation through a 25%
glycerol cushion (Beckman SW55 rotor, 2 h, 50,000, 4 -C) and
directly resuspended in SDS sample buffer.
Virus titration
SeVand rSeV plaque assays were done on LLC-MK2 under
a 0.3% agarose overlay in the presence of 2 Ag/ml of acetylated
trypsin according to Sugita et al. (1974).
Acknowledgments
This work was supported by grants from the Swiss National
Foundation for Scientific Research and from the Commission
of the European Communities specific RTD programme
‘‘Quality of Life and Management of Living Resources’’,
QLK2-CT2001-01225, ‘‘Towards the design of new potent
antiviral drugs: structure and function analysis of Paramyx-
oviridae RNA polymerase’’. It does not necessary reflect the
views of the Commission and in no way anticipates future
policy in this area. The authors are indebted to Laurence
Abrami, Frank Lafont and Gisou van der Goot (Departement of
Microbiologiy and Molecular Medicine, University of Geneva
Medical School) for sharing their expertise about rafts and for
making available their reagents. Frank Lafont (Institut Pasteur
de Lille, France) and Dave Rowlands (Leeds University, UK)
are also thanked for critical reading of the manuscript.
References
Abrami, L., Liu, S., Cosson, P., Leppla, S.H., van der Goot, F.G., 2003.
Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated
clathrin-dependent process. J. Cell Biol. 160, 321–328.
Ali, A., Nayak, D.P., 2000. Assembly of sendai virus: M protein interacts with
F and HN proteins and with the cytoplasmic tail and transmembrane
domain of F protein. Virology 276, 289–303.Ali, A., Avalos, R.T., Ponimaskin, E., Nayak, D.P., 2000. Influenza virus
assembly: effect of influenza virus glycoproteins on the membrane
association of M1 protein. J. Virol. 74, 8709–8719.
Bavari, S., Bosio, C.M., Wiegand, E., Ruthel, G., Will, A.B., Geisbert, T.W.,
Hevey, M., Schmaljohn, C., Schmaljohn, A., Aman, M.J., 2002. Lipid raft
microdomains: a gateway for compartmentalized trafficking of Ebola and
Marburg viruses. J. Exp. Med. 195, 593–602.
Brown, G., Rixon, H.W.M., Sugrue, R.J., 2002. Respiratory syncytial virus
assembly occurs in GM1-rich regions of the host-cell membrane and alters
the cellular distribution of tyrosine phosphorylated caveolin-1. J. Gen.
Virol. 83, 1841–1850.
Chazal, N., Gerlier, D., 2003. Virus entry, assembly, budding, and membrane
rafts. Microbiol. Mol. Biol. Rev. 67, 226–237 (table).
Dolganiuc, V., McGinnes, L., Luna, E.J., Morrison, T.G., 2003. Role of the
cytoplasmic domain of the Newcastle disease virus fusion protein in
association with lipid rafts. J. Virol. 77, 12968–12979.
Edidin, M., 1997. Lipid microdomains in cell surface membranes. Curr. Opin.
Struct. Biol. 7, 528–532.
Fouillot-Coriou, N., Roux, L., 2000. Structure– function analysis of the sendai
virus F and HN cytoplasmic domain: different role for the two proteins in
the production of virus particle. Virology 270, 464–475.
Golub, T., Pico, C., 2005. Spatial control of actin-based motility through
plasmalemmal PtdIns(4,5)P2-rich raft assemblies. Biochem. Soc. Symp.,
119–127.
Harder, T., Simons, K., 1997. Caveolae, DIGs, and the dynamics of
sphingolipid-cholesterol microdomains. Curr. Opin. Cell Biol. 9, 534–542.
Ikonen, E., 2001. Roles of lipid rafts in membrane transport. Curr. Opin. Cell
Biol. 13, 470–477.
Keller, P., Simons, K., 1998. Cholesterol is required for surface transport of
influenza virus hemagglutinin. J. Cell Biol. 140, 1357–1367.
Kurzchalia, T.V., Parton, R.G., 1999. Membrane microdomains and caveolae.
Curr. Opin. Cell Biol. 11, 424–431.
Lafont, F., van der Goot, F.G., 2005. Oiling the key hole. Mol. Microbiol. 56,
575–577.
Lafont, F., Tran Van, N.G., Hanada, K., Sansonetti, P., van der Goot, F.G., 2002.
Initial steps of Shigella infection depend on the cholesterol/sphingolipid
raft-mediated CD44– IpaB interaction. EMBO J. 21, 4449–4457.
Manes, S., del Real, G., Martinez, A., 2003. Pathogens: raft hijackers. Nat. Rev.
Immunol. 3, 557–568.
Manie, S.N., Debreyne, S., Vincent, S., Gerlier, D., 2000. Measles virus
structural components are enriched into lipid raft microdomains: a potential
cellular location for virus assembly [In Process Citation]. J. Virol. 74,
305–311.
Mottet, G., Portner, A., Roux, L., 1986. Drastic immunoreactivity changes
between the immature and mature forms of the Sendai virus HN and Fo
glycoproteins. J. Virol. 59, 132–141.
Mottet, G., Mu¨hlemann, A., Tapparel, C., Hoffmann, F., Roux, L., 1996. A
Sendai virus vector leading to the efficient expression of mutant M proteins
interfering with virus particle budding. Virology 221, 159–171.
Mottet, G., Mu¨ller, V., Roux, L., 1999. Characterization of Sendai virus M
protein mutants that can partially interfere with virus particle production.
J. Gen. Virol. 80, 2977–2986.
Nayak, D.P., Barman, S., 2002. Role of lipid rafts in virus assembly and
budding. Adv. Virus Res. 58, 1–28.
Nguyen, D.H., Hildreth, J.E., 2000. Evidence for budding of human immuno-
deficiency virus type 1 selectively from glycolipid-enriched membrane lipid
rafts. J. Virol. 74, 3264–3272.
Panchal, R.G., Ruthel, G., Kenny, T.A., Kallstrom, G.H., Lane, D., Badie,
S.S., Li, L., Bavari, S., Aman, M.J., 2003. In vivo oligomerization and
raft localization of Ebola virus protein VP40 during vesicular budding.
Proc. Natl. Acad. Sci. U.S.A. 100, 15936–15941.
Parton, R.G., Richards, A.A., 2003. Lipid rafts and caveolae as portals for
endocytosis: new insights and common mechanisms. Traffic 4, 724–738.
Pelkmans, L., 2005. Viruses as probes for systems analysis of cellular
signalling, cytoskeleton reorganization and endocytosis. Curr. Opin.
Microbiol. 8, 331–337.
Pelkmans, L., Helenius, A., 2003. Insider information: what viruses tell us
about endocytosis. Curr. Opin. Cell Biol. 15, 414–422.
A.-S. Gosselin-Grenet et al. / Virology 344 (2006) 296–303 303Roux, L., Holland, J.J., 1979. Role of defective interfering particles of Sendai
virus in persistent infections. Virology 93, 91–103.
Sanderson, C.M., Avalos, R., Kundu, A., Nayak, D.P., 1995. Interaction
of Sendai viral F, HN and M proteins with host cytoskeletal and
lipid components in Sendai virus-infected BHK cells. Virology 209,
701–707.
Sandrin, V., Muriaux, D., Darlix, J.L., Cosset, F.L., 2004. Intracellular
trafficking of Gag and Env proteins and their interactions modulate
pseudotyping of retroviruses. J. Virol. 78, 7153–7164.
Scheiffele, P., Roth, M.G., Simons, K., 1997. Interaction of influenza virus
haemagglutinin with sphingolipid-cholesterol membrane domains via its
transmembrane domain. EMBO J. 16, 5501–5508.
Scheiffele, P., Rietveld, A., Wilk, T., Simons, K., 1999. Influenza viruses select
ordered lipid domains during budding from the plasma membrane. J. Biol.
Chem. 274, 2038–2044.
Simons, K., Ikonen, E., 1997. Functional rafts in cell membranes. Nature 387,
569–572.Simons, K., Toorme, D., 2000. Lipid rafts and signal transduction. Nat. Rev.,
Mol. Cell Biol. 1, 31–39.
Sugita, K., Maru, M., Sato, K., 1974. A sensitive plaque assay for Sendai
virus in established line of monkey kidney cells. Jpn. J. Microbiol. 18,
262–264.
Takimoto, T., Portner, A., 2004. Molecular mechanism of paramyxovirus
budding. Virus Res. 106, 133–145.
Tuffereau, C., Roux, L., 1988. Direct adverse effects of Sendai virus DI
particles on virus budding and on M protein stability. Virology 162,
417–426.
van Meer, G., Sprong, H., 2004. Membrane lipids and vesicular traffic. Curr.
Opin. Cell Biol. 16, 373–378.
Vincent, S., Gerlier, D., Manie, S.N., 2000. Measles virus assembly within
membrane rafts. J. Virol. 74, 9911–9915.
Wiznerowicz, M., Trono, D., 2003. Conditional suppression of cellular genes:
lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77,
8951–8957.
